Allakos Inc.·4

May 15, 4:03 PM ET

James Steven P 4

4 · Allakos Inc. · Filed May 15, 2025

Insider Transaction Report

Form 4
Period: 2025-05-15
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1555,3800 total
    Exercise: $0.53Exp: 2026-04-28Common Stock (55,380 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1518,8000 total
    Exercise: $16.00Exp: 2028-07-06Common Stock (18,800 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1516,0000 total
    Exercise: $40.00Exp: 2029-06-06Common Stock (16,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-157,7000 total
    Exercise: $72.54Exp: 2030-05-26Common Stock (7,700 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-157,7000 total
    Exercise: $99.83Exp: 2031-05-25Common Stock (7,700 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1599,5900 total
    Exercise: $2.62Exp: 2032-05-25Common Stock (99,590 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1586,7620 total
    Exercise: $4.81Exp: 2033-05-25Common Stock (86,762 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-1541,0000 total
    Exercise: $1.42Exp: 2034-05-24Common Stock (41,000 underlying)
Footnotes (1)
  • [F1]This option was cancelled without consideration pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc.

Documents

1 file
  • 4
    tm2514731-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT